Nova EYE Medical Ltd (EYE) - Total Assets
Based on the latest financial reports, Nova EYE Medical Ltd (EYE) holds total assets worth AU$23.67 Million AUD (≈ $16.75 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check EYE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Nova EYE Medical Ltd - Total Assets Trend (1989–2025)
This chart illustrates how Nova EYE Medical Ltd's total assets have evolved over time, based on quarterly financial data. Check EYE cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Nova EYE Medical Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Nova EYE Medical Ltd's total assets of AU$23.67 Million consist of 46.5% current assets and 53.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$5.05 Million | 19.1% |
| Accounts Receivable | AU$4.18 Million | 15.8% |
| Inventory | AU$2.81 Million | 10.6% |
| Property, Plant & Equipment | AU$3.36 Million | 12.7% |
| Intangible Assets | AU$6.86 Million | 25.9% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (1989–2025)
This chart illustrates how Nova EYE Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Nova EYE Medical Ltd (EYE) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nova EYE Medical Ltd's current assets represent 46.5% of total assets in 2025, an increase from 35.7% in 1989.
- Cash Position: Cash and equivalents constituted 19.1% of total assets in 2025, up from 5.1% in 1989.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 25.0% of total assets, an increase from 0.0% in 1989.
- Asset Diversification: The largest asset category is intangible assets at 25.9% of total assets.
Nova EYE Medical Ltd Competitors by Total Assets
Key competitors of Nova EYE Medical Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Inspire Medical Systems Inc
NYSE:INSP
|
USA | $911.38 Million |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186
|
China | CN¥1.59 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Stratec SE
XETRA:SBS
|
Germany | €443.38 Million |
|
Scandinavian Medical Solutions AS
CO:SMSMED
|
Denmark | Dkr205.86 Million |
|
Duearity AB
ST:DEAR
|
Sweden | Skr10.84 Million |
Nova EYE Medical Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.85 | 1.84 | 2.94 |
| Quick Ratio | 1.24 | 1.04 | 2.68 |
| Cash Ratio | 0.46 | 0.41 | 2.32 |
| Working Capital | AU$4.85 Million | AU$4.56 Million | AU$24.60 Million |
Nova EYE Medical Ltd - Advanced Valuation Insights
This section examines the relationship between Nova EYE Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.12 |
| Latest Market Cap to Assets Ratio | 0.84 |
| Asset Growth Rate (YoY) | -11.3% |
| Total Assets | AU$26.50 Million |
| Market Capitalization | $22.17 Million USD |
Valuation Analysis
Near Book Valuation: The market values Nova EYE Medical Ltd's assets close to their book value (0.84x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Nova EYE Medical Ltd's assets decreased by 11.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nova EYE Medical Ltd (1989–2025)
The table below shows the annual total assets of Nova EYE Medical Ltd from 1989 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$26.50 Million ≈ $18.75 Million |
-11.30% |
| 2024-06-30 | AU$29.88 Million ≈ $21.14 Million |
-1.56% |
| 2023-06-30 | AU$30.36 Million ≈ $21.48 Million |
-17.11% |
| 2022-06-30 | AU$36.62 Million ≈ $25.91 Million |
-12.79% |
| 2021-06-30 | AU$41.99 Million ≈ $29.71 Million |
-64.03% |
| 2020-06-30 | AU$116.74 Million ≈ $82.60 Million |
+16.87% |
| 2019-06-30 | AU$99.89 Million ≈ $70.68 Million |
-3.45% |
| 2018-06-30 | AU$103.47 Million ≈ $73.21 Million |
+19.55% |
| 2017-06-30 | AU$86.54 Million ≈ $61.23 Million |
+20.21% |
| 2016-06-30 | AU$71.99 Million ≈ $50.94 Million |
+22.06% |
| 2015-06-30 | AU$58.98 Million ≈ $41.73 Million |
+8.76% |
| 2014-06-30 | AU$54.23 Million ≈ $38.37 Million |
+14.54% |
| 2013-06-30 | AU$47.35 Million ≈ $33.50 Million |
+5.37% |
| 2012-06-30 | AU$44.93 Million ≈ $31.79 Million |
-7.13% |
| 2011-06-30 | AU$48.38 Million ≈ $34.23 Million |
-6.20% |
| 2010-06-30 | AU$51.58 Million ≈ $36.49 Million |
+1.32% |
| 2009-06-30 | AU$50.91 Million ≈ $36.02 Million |
-29.24% |
| 2008-06-30 | AU$71.94 Million ≈ $50.90 Million |
+12.96% |
| 2007-06-30 | AU$63.69 Million ≈ $45.06 Million |
+37.03% |
| 2006-06-30 | AU$46.48 Million ≈ $32.88 Million |
+19.00% |
| 2005-06-30 | AU$39.05 Million ≈ $27.63 Million |
+1.93% |
| 2004-06-30 | AU$38.31 Million ≈ $27.11 Million |
+3.34% |
| 2003-06-30 | AU$37.08 Million ≈ $26.23 Million |
-4.37% |
| 2002-06-30 | AU$38.77 Million ≈ $27.43 Million |
+3283.99% |
| 2001-06-30 | AU$1.15 Million ≈ $810.63K |
+114.51% |
| 2000-06-30 | AU$534.07K ≈ $377.89K |
-5.82% |
| 1999-06-30 | AU$567.06K ≈ $401.23K |
-44.12% |
| 1998-06-30 | AU$1.01 Million ≈ $718.09K |
-41.42% |
| 1997-06-30 | AU$1.73 Million ≈ $1.23 Million |
-1.68% |
| 1996-06-30 | AU$1.76 Million ≈ $1.25 Million |
+43.73% |
| 1995-06-30 | AU$1.23 Million ≈ $867.47K |
+301.97% |
| 1994-06-30 | AU$305.00K ≈ $215.81K |
-44.04% |
| 1993-06-30 | AU$545.00K ≈ $385.62K |
-35.43% |
| 1992-06-30 | AU$844.00K ≈ $597.18K |
-29.55% |
| 1991-06-30 | AU$1.20 Million ≈ $847.66K |
-13.94% |
| 1990-06-30 | AU$1.39 Million ≈ $984.93K |
-64.11% |
| 1989-06-30 | AU$3.88 Million ≈ $2.74 Million |
-- |
About Nova EYE Medical Ltd
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degen… Read more